BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential to match the efficacy of the blockbuster Takeda Pharmaceutical drug that currently dominates the market, but with less burdensome dosing that could encourage HAE patients to switch. The post BioCryst’s…
This analysis estimates that 48% of adults under age 65 with individual market coverage are either employed by a small business with fewer than 25 workers, self-employed entrepreneurs, or small business owners. Because the vast majority of this coverage is purchased through the Affordable Care Act (ACA) Marketplaces, changes to the ACA, including the expiration…
AHA’s new report shows hospital performance on safety measures and quality is better than it was pre-pandemic
Fawad Butt, CEO of Penguin Ai, gave his candid thoughts on where the healthcare AI market is headed, including how data leakage could be fueling smarter AI models and the limits of agentic AI in enterprise settings. The post Why Agentic AI is Useful But Limited & Other Hot Takes on the AI Market appeared…
It reduced cravings, dulled alcohol’s “buzz,” and carried no risk of addiction. By every measure, naltrexone should have immediately become a major triumph. Instead, it flopped because the institutions charged with treating addiction refused to use it. Now considered a gold standard, it survived because patients and communities kept it alive. The post The Pill Patients…
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Many companies are entering the digital youth mental health space, but it’s important to know which ones are effective, according to a panel of investors at the Behavioral Health Tech conference. The post Measuring Impact in Digital Youth Mental Health: What Investors Look For appeared first on MedCity News.
Potential health policy administrative actions under the incoming Trump administration based on campaign positions and statements by President-elect Trump, President Trump’s record during his first administration, and expected actions that would reverse or modify regulations or guidance issued by the Biden administration
In the US, opioid abuse has become and epidemic. However, in the past year, there is some hope that this epidemic is starting to reverse. Opioid deaths have fallen by 16.9% in the past year. Why have deaths fallen? According to The Economist, no one is sure: One possibility is a supply shock…the amount of…
Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…